Related Experiment Videos
Cardiac markers and risk stratification: an integrated approach
M Galvani1, D Ferrini, F Ghezzi
1Cardiovascular Research Unit, Fondazione Sacco, Forlì, Italy. galvanim@tin.it
Clinica Chimica Acta; International Journal of Clinical Chemistry
|September 15, 2001
Summary
This study assessed biochemical markers for acute coronary syndromes (ACS) risk. Cardiac troponins, D-dimer, and C-reactive protein help predict major cardiac events in ACS patients.
Area of Science:
- Cardiology
- Biomarker Research
- Clinical Risk Stratification
Background:
- Accurate risk stratification in acute coronary syndromes (ACS) is crucial for resource allocation and treatment optimization.
- Existing clinical and electrocardiographic indicators have limitations in predicting major cardiac events.
- Biomarkers offer complementary information, but their independent prognostic value in unselected ACS patients requires further investigation.
Purpose of the Study:
- To prospectively evaluate the prognostic value of various biochemical markers in a broad spectrum of ACS patients.
- To determine if biomarkers of myocardial damage, hemostasis, and inflammation add independent prognostic information beyond clinical and electrocardiographic data.
- To compare the prognostic utility of different biomarkers in predicting adverse outcomes in ACS.
Main Methods:
- The Early Prognostic Value of Biochemical Markers of Myocardial Damage, Activation of Hemostatic Mechanism and Inflammation in Acute Ischemic Syndromes (EMAI) study prospectively enrolled 1971 ACS patients.
- Patients were admitted to 31 Italian Coronary Care Units with rest anginal pain and ECG evidence of ischemia.
- Measured biomarkers included cardiac troponin I (cTnI), cardiac troponin T (cTnT), D-dimer, prothrombin fragment 1+2 (F1+2), thrombin-antithrombin complex (TAT), and C-reactive protein (CRP).
Main Results:
- Elevations in cardiac troponin I (cTnI) and cardiac troponin T (cTnT) were strongly associated with a high-risk profile.
- The study evaluated the prognostic value of cTnI, cTnT, D-dimer, F1+2, TAT, and CRP in ACS patients.
- The primary outcome of death or non-fatal myocardial infarction (MI) within 30 days occurred in 8.9% of the study population.
Conclusions:
- Biomarkers like cardiac troponins provide significant prognostic information in ACS patients.
- Further analysis is needed to clarify the independent contribution of hemostasis and inflammation markers to risk stratification in ACS.
- The EMAI study provides valuable data on the role of biochemical markers in managing ACS patients.